Cargando…

Proper time to initiate antiosteoporotic treatment in rheumatoid arthritis with or without glucocorticoid use

Detalles Bibliográficos
Autor principal:	Lee, Sang-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101589/ https://www.ncbi.nlm.nih.gov/pubmed/25045290 http://dx.doi.org/10.3904/kjim.2014.29.4.434

Ejemplares similares

Are glucocorticoid-induced osteoporosis recommendations sufficient to determine antiosteoporotic treatment for patients with rheumatoid arthritis?
por: Lee, Joo-Hyun, et al.
Publicado: (2014)

The use of glucocorticoids in rheumatoid arthritis - no 'rational' approach yet
por: Desai, Sonali P, et al.
Publicado: (2010)

Assessment of the antiosteoporotic treatment initiation: A retrospective observational study in Greece
por: Rizou, Stavroula, et al.
Publicado: (2017)

Long-term treatment with low dose glucocorticoids in Rheumatoid Arthritis: New tricks of an old drug
por: Nikas, Spyros N.
Publicado: (2018)

Antiosteoporotic effect of Petroselinum crispum, Ocimum basilicum and Cichorium intybus L. in glucocorticoid-induced osteoporosis in rats
por: Hozayen, Walaa G., et al.
Publicado: (2016)

Glucocorticoids and chronotherapy in rheumatoid arthritis
por: Cutolo, Maurizio
Publicado: (2016)

Perspectives of Glucocorticoid Use in Patients with Rheumatoid Arthritis
por: Venter, Gabriella, et al.
Publicado: (2021)

Nigella sativa: A Potential Antiosteoporotic Agent
por: Shuid, Ahmad Nazrun, et al.
Publicado: (2012)

Why and how to optimize glucocorticoid treatment in rheumatoid arthritis
por: Cutolo, Maurizio
Publicado: (2012)

Isolation of Antiosteoporotic Compounds from Seeds of Sophora japonica
por: Abdallah, Hossam M., et al.
Publicado: (2014)

Viewpoint: Glucocorticoids in the treatment of rheumatoid arthritis: points to (re)consider
por: Boers, Maarten
Publicado: (2023)

Proper management of rheumatoid arthritis in Latin America. What the guidelines say?
por: Brenol, Claiton V., et al.
Publicado: (2015)

Early Testing and Prompt Initiation of Proper Treatment: a Clever Strategy to Fight with Tuberculosis Pericarditis
por: Cho, Iksung, et al.
Publicado: (2020)

Antiosteoporotic Effect of Combined Extract of Morus alba and Polygonum odoratum
por: Sungkamanee, Sudarat, et al.
Publicado: (2014)

Potential Antiosteoporotic Agents from Plants: A Comprehensive Review
por: Jia, Min, et al.
Publicado: (2012)

Antiosteoporotic Activity of Anthraquinones from Morinda officinalis on Osteoblasts and Osteoclasts
por: Wu, Yan-Bin, et al.
Publicado: (2009)

Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis
por: Kavanaugh, Arthur, et al.
Publicado: (2014)

Polymorphisms in the glucocorticoid receptor gene that modulate glucocorticoid sensitivity are associated with rheumatoid arthritis
por: van Oosten, Manon JM, et al.
Publicado: (2010)

In vitro glucocorticoid sensitivity is associated with clinical glucocorticoid therapy outcome in rheumatoid arthritis
por: Quax, Rogier AM, et al.
Publicado: (2012)

Rheumatoid Arthritis
por: Melchiorre, Daniela, et al.
Publicado: (2013)

Biomarkers for Treatment Response in Rheumatoid Arthritis: Where are they?
por: Zhao, Sizheng Steven, et al.
Publicado: (2020)

Glucocorticoid receptor gene polymorphisms and susceptibility to rheumatoid arthritis
por: Donn, Rachelle, et al.
Publicado: (2007)

Glucocorticoids in rheumatoid arthritis: current status and future studies
por: Hua, Charlotte, et al.
Publicado: (2020)

Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis
por: Riley, Thomas R, et al.
Publicado: (2021)

Systemic Manifestations and Complications in Patients with Rheumatoid Arthritis
por: Kim, Ji-Won, et al.
Publicado: (2020)

Erratum to: Proper management of rheumatoid arthritis in Latin America. What the guidelines say?
por: Brenol, Claiton V., et al.
Publicado: (2015)

292 Fibromyalgianess and Glucocorticoid Persistence Among Patients with Rheumatoid Arthritis
por: Wallace, Beth, et al.
Publicado: (2022)

Wnt-Signaling-Mediated Antiosteoporotic Activity of Porcine Placenta Hydrolysates in Ovariectomized Rats
por: Ko, Byoung-Seob, et al.
Publicado: (2012)

Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis
por: van Ouwerkerk, Lotte, et al.
Publicado: (2023)

Antiosteoporotic effects of Polycan in combination with calcium lactate-gluconate in ovariectomized rats
por: CHOI, JAE-SUK, et al.
Publicado: (2014)

The Antiosteoporotic Activity of Central-Icaritin (CIT) on Bone Metabolism of Ovariectomized Rats
por: Jiang, Jun, et al.
Publicado: (2014)

Biomarkers in Rheumatoid Arthritis
por: Goëb, Vincent, et al.
Publicado: (2014)

Vasculogenesis in rheumatoid arthritis
por: Szekanecz, Zoltán, et al.
Publicado: (2010)

Rheumatoid Arthritis in Minorities
por: Anaya, Juan-Manuel, et al.
Publicado: (2013)

Atherosclerosis in Rheumatoid Arthritis
por: González-Gay, Miguel A., et al.
Publicado: (2012)

Fatigue in rheumatoid arthritis
por: Choy, Ernest H, et al.
Publicado: (2019)

How to properly use the PRISMA Statement
por: Sarkis-Onofre, Rafael, et al.
Publicado: (2021)

Rituximab treatment in rheumatoid arthritis: how does it work?
por: Boumans, Maria JH, et al.
Publicado: (2009)

Heterogeneity in rheumatoid arthritis-associated interstitial lung disease: time for splitting?
por: Kawano-Dourado, Leticia, et al.
Publicado: (2022)

Use of administrative claims data for comparative effectiveness research of rheumatoid arthritis treatments
por: Kim, Seo Young, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_51gmt4t94d7hffsqgj8907etou